Originally published byDW News
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder into a biotech giant?
🇩🇪
More news from GermanyGermany
EUROPE
Related News
Germany news: National team won't win World Cup, fans think
19h ago
Pigeons' livers may enable magnetic navigation when the sun doesn't shine, study finds
19h ago
Paddleboard firm owner who caused four deaths has bid to cut sentence refused
21h ago
Former student charged after University of Surrey crossbow attack
23h ago
The Papers: 'Flagship breaks down' and 'Beer we go!'
9h ago